BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

526 related articles for article (PubMed ID: 33744415)

  • 1. Characteristics of fatal opioid overdoses with stimulant involvement in Tennessee: A descriptive study using 2018 State Unintentional Drug Overdose Reporting System Data.
    Korona-Bailey JA; Nechuta S; Golladay M; Moses J; Bastasch O; Krishnaswami S
    Ann Epidemiol; 2021 Jun; 58():149-155. PubMed ID: 33744415
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Prevalence of hepatitis C virus among fatal drug overdoses in Tennessee: an analysis using 2019-2020 Tennessee State Unintentional Drug Overdose Reporting System Data.
    Korona-Bailey J; Riley Saint S; Sizemore L; Wingate H; Shoup P; Hawes A; Mukhopadhyay S
    Ann Epidemiol; 2023 Apr; 80():1-8. PubMed ID: 36758846
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Exploring trends in benzodiazepine-positive fatal drug overdoses in Tennessee, 2019-2021.
    Moses J; Korona-Bailey J; Mukhopadhyay S
    Ann Med; 2023; 55(2):2287194. PubMed ID: 38039554
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Diphenhydramine-involved Fatal and Nonfatal Drug Overdoses in Tennessee, 2019-2022.
    Saint SR; Onyango E; Korona-Bailey J; Jayasundara J; Hall K; Mukhopadhyay S
    Subst Use Misuse; 2024; 59(4):638-642. PubMed ID: 38189325
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Phentermine involvement in fatal drug overdoses in Tennessee, 2019-2022.
    Hall KF; Korona-Bailey J; Mukhopadhyay S
    Int J Drug Policy; 2023 Sep; 119():104151. PubMed ID: 37549596
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Trends in unintentional polysubstance overdose deaths and individual and community correlates of polysubstance overdose, North Carolina, 2009-2018.
    Figgatt MC; Austin AE; Cox ME; Proescholdbell S; Marshall SW; Naumann RB
    Drug Alcohol Depend; 2021 Feb; 219():108504. PubMed ID: 33429292
    [TBL] [Abstract][Full Text] [Related]  

  • 7. The rise in non-fatal and fatal overdoses involving stimulants with and without opioids in the United States.
    Hoots B; Vivolo-Kantor A; Seth P
    Addiction; 2020 May; 115(5):946-958. PubMed ID: 31912625
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Vital Signs: Characteristics of Drug Overdose Deaths Involving Opioids and Stimulants - 24 States and the District of Columbia, January-June 2019.
    O'Donnell J; Gladden RM; Mattson CL; Hunter CT; Davis NL
    MMWR Morb Mortal Wkly Rep; 2020 Sep; 69(35):1189-1197. PubMed ID: 32881854
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Sociodemographic factors, prescription history and opioid overdose deaths: a statewide analysis using linked PDMP and mortality data.
    Nechuta SJ; Tyndall BD; Mukhopadhyay S; McPheeters ML
    Drug Alcohol Depend; 2018 Sep; 190():62-71. PubMed ID: 29981943
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Charting the fourth wave: Geographic, temporal, race/ethnicity and demographic trends in polysubstance fentanyl overdose deaths in the United States, 2010-2021.
    Friedman J; Shover CL
    Addiction; 2023 Dec; 118(12):2477-2485. PubMed ID: 37705148
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Preventing Overdoses Involving Stimulants: The POINTS Study Protocol.
    Hughto J; Rich J; Kelly P; Veno S; Silcox J; Noh M; Pletta D; Erowid E; Erowid F; Green T
    Res Sq; 2024 Mar; ():. PubMed ID: 38559156
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Estimating the ratio of fatal to non-fatal overdoses involving all drugs, all opioids, synthetic opioids, heroin or stimulants, USA, 2010-2020.
    Casillas SM; Pickens CM; Tanz LJ; Vivolo-Kantor AM
    Inj Prev; 2024 Mar; 30(2):114-124. PubMed ID: 38290778
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Examining the neighborhood-level socioeconomic characteristics associated with fatal overdose by type of drug involved and overdose setting.
    Chichester K; Drawve G; Sisson M; McCleskey B; Dye DW; Cropsey K
    Addict Behav; 2020 Dec; 111():106555. PubMed ID: 32717498
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Using statewide death certificate data to understand trends and characteristics of polydrug overdose deaths in Tennessee, 2013-2017.
    Golladay M; Donner K; Nechuta S
    Ann Epidemiol; 2020 Jan; 41():43-48.e1. PubMed ID: 31928897
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Using death scene and toxicology evidence to define involvement of heroin, pharmaceutical morphine, illicitly manufactured fentanyl and pharmaceutical fentanyl in opioid overdose deaths, 38 states and the District of Columbia, January 2018-December 2019.
    O'Donnell J; Gladden RM; Kariisa M; Mattson CL
    Addiction; 2022 May; 117(5):1483-1490. PubMed ID: 34882865
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Worldwide Prevalence and Trends in Unintentional Drug Overdose: A Systematic Review of the Literature.
    Martins SS; Sampson L; Cerdá M; Galea S
    Am J Public Health; 2015 Nov; 105(11):e29-49. PubMed ID: 26451760
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Worldwide Prevalence and Trends in Unintentional Drug Overdose: A Systematic Review of the Literature.
    Martins SS; Sampson L; Cerdá M; Galea S
    Am J Public Health; 2015 Nov; 105(11):2373. PubMed ID: 26451757
    [TBL] [Abstract][Full Text] [Related]  

  • 18. The Contribution of Prescribed and Illicit Opioids to Fatal Overdoses in Massachusetts, 2013-2015.
    Walley AY; Bernson D; Larochelle MR; Green TC; Young L; Land T
    Public Health Rep; 2019; 134(6):667-674. PubMed ID: 31577519
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Heroin and fentanyl overdoses in Kentucky: Epidemiology and surveillance.
    Slavova S; Costich JF; Bunn TL; Luu H; Singleton M; Hargrove SL; Triplett JS; Quesinberry D; Ralston W; Ingram V
    Int J Drug Policy; 2017 Aug; 46():120-129. PubMed ID: 28735777
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Patient characteristics and treatment utilization in fatal stimulant-involved overdoses in the United States Veterans Health Administration.
    Coughlin LN; Zhang L; Bohnert ASB; Maust DT; Goldstick J; Lin LA
    Addiction; 2022 Apr; 117(4):998-1008. PubMed ID: 34648209
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 27.